Licensing deal takes Brilliance's neonatal jaundice treatment to India

Fast Company report on a 2009 NCIIA Sustainable Vision team from Stanford University...

Working with D-Rev, a nonprofit technology incubator based in Palo Alto, the Enabling Effective Management of Neonatal Jaundice in Rural India team signed a licensing agreement with Chennai, India-based Phoenix Medical Systems Private Ltd for the manufacturing and distribution of Brilliance, a novel phototherapy device that enables the treatment of severe neonatal jaundice in low-resource hospitals.